These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24403895)

  • 1. PET-Negative Gastrointestinal Stromal Tumors.
    Williams A; Gutzeit A; Germer M; Pless M
    Case Rep Oncol; 2013; 6(3):508-13. PubMed ID: 24403895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of preoperative
    Miyake KK; Nakamoto Y; Mikami Y; Tanaka S; Higashi T; Tadamura E; Saga T; Minami S; Togashi K
    Eur Radiol; 2016 Dec; 26(12):4664-4674. PubMed ID: 26852217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: detection of multiple sporadic gastrointestinal stromal tumors by dual-time
    Li C; Li W; Shang M; Wang P; Hu X
    Front Oncol; 2024; 14():1321179. PubMed ID: 38606109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
    Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
    J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors.
    Stefanelli A; Treglia G; Mirk P; Muoio B; Giordano A
    ISRN Gastroenterol; 2011; 2011():824892. PubMed ID: 21991530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rectal gastrointestinal stromal tumor case accompanied by elevated CEA mimicking rectal carcinoma on
    Tao Z; Wu S; Chen Z; Qiu Y; Song L; Yang Q; Nong L; Kang L
    Am J Nucl Med Mol Imaging; 2023; 13(1):26-32. PubMed ID: 36923597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.
    Watabe T; Tatsumi M; Watabe H; Isohashi K; Kato H; Yanagawa M; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2012 Apr; 26(3):222-7. PubMed ID: 22187313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
    Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
    World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors.
    Otomi Y; Otsuka H; Morita N; Terazawa K; Furutani K; Harada M; Nishitani H
    J Med Invest; 2010 Aug; 57(3-4):270-4. PubMed ID: 20847527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of F-18-FDG-PET/CT in restaging of patients affected by gastrointestinal stromal tumours (GIST).
    Bertagna F; Bosio G; Orlando E; Biasiotto G; Giubbini R
    Nucl Med Rev Cent East Eur; 2010; 13(2):76-80. PubMed ID: 21598231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
    Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
    Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
    Montemurro M; Cioffi A; Dômont J; Rutkowski P; Roth AD; von Moos R; Inauen R; Toulmonde M; Burkhard RO; Knuesli C; Bauer S; Cassier P; Schwarb H; Le Cesne A; Koeberle D; Bärtschi D; Dietrich D; Biaggi C; Prior J; Leyvraz S
    Cancer; 2018 Apr; 124(7):1449-1454. PubMed ID: 29315500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M; Majidi M; Lasota J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
    Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
    BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively.
    Park JW; Cho CH; Jeong DS; Chae HD
    J Gastric Cancer; 2011 Sep; 11(3):173-9. PubMed ID: 22076223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of 18F-fluorodeoxyglucose positron emission tomography in gastrointestinal stromal tumor of the esophagus.
    Sakai M; Kato H; Saito K; Tanaka N; Inose T; Kimura H; Miyazaki T; Kuwano H
    Int Surg; 2008; 93(4):209-13. PubMed ID: 19731855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Evaluation of Response Using
    Farag S; Geus-Oei LF; van der Graaf WT; van Coevorden F; Grunhagen D; Reyners AKL; Boonstra PA; Desar I; Gelderblom H; Steeghs N
    J Nucl Med; 2018 Feb; 59(2):194-196. PubMed ID: 28970330
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
    Cho MH; Park CK; Park M; Kim WK; Cho A; Kim H
    PLoS One; 2015; 10(10):e0141413. PubMed ID: 26509967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.